Quantum Biopharma Class B Subordinate Voting Shares
QNTM
17 hedge funds and large institutions have $2.38M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
330% more capital invested
Capital invested by funds: $553K → $2.38M (+$1.82M)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
21% more funds holding
Funds holding: 14 → 17 (+3)
0.18% more ownership
Funds ownership: 3.64% → 3.83% (+0.18%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$546K |
| 2 |
VF
Virtu Financial
New York
|
+$206K |
| 3 |
LPL Financial
San Diego,
California
|
+$135K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$38.2K |
| 5 |
JP Morgan Chase
New York
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$148K |
| 2 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
-$97.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$32.7K |
| 4 |
Morgan Stanley
New York
|
-$29.6K |
| 5 |
TIM
Thompson Investment Management
Madison,
Wisconsin
|
-$2.51K |
QNTM Hedge Fund Activity: Q2 2025 in Review
17 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q2 2025, worth a combined $2.38M — up 330% from $553K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new QNTM positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was UBS Group, adding an estimated $546K. The largest seller was AdvisorShares Investments, cutting an estimated $148K.
- 17 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q2 2025, up from 14 in Q1 2025.
- Funds reported $2.38M of Quantum Biopharma Class B Subordinate Voting Shares stock for Q2 2025, up 330% quarter-over-quarter.
- 6 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q2 2025 and 3 closed out, a net change of +3 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q2 2025 was UBS Group, an estimated $546K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q2 2025 was AdvisorShares Investments, an estimated $148K sold.
Based on aggregated 13F filings for Q2 2025.